In Mirisan Rehabilitation is categorized under Physical Medicine, Physician/Surgeon in Miami, FL and active since 2006.
In Mirisan Rehabilitation was established in 2006, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Physical Medicine, Physician/Surgeon business, which does work in the B2C market, and is classified as a Physical Medicine, Physician/Surgeon, under code number 621111 by the NAICS.
If you are seeking more information, feel free to contact Santiago Pedro Bello at the company’s single location by writing to 7000 Sw 97th Avenue # 106, Miami, Florida FL 33173 or by phoning No number given. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | In Mirisan Rehabilitation |
| Contact Person: | Santiago Pedro Bello |
| Address: | 7000 Sw 97th Avenue # 106, Miami, Florida 33173 |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 2006 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Physical Medicine, Physician/Surgeon |
| SIC Code: | 8011 |
| NAICS Code: | 621111 |
| Share This Business: |
In Mirisan Rehabilitation was started in 2006 to provide professional Physical Medicine, Physician/Surgeon under the SIC code 8011 and NAICS code 621111. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Santiago Pedro Bello for inquiries that concern In Mirisan Rehabilitation by calling the company number No number given, as your correspondence is most welcome. Additionally, the physical location of the single location of In Mirisan Rehabilitation can be found at the coordinates as well as the street address 7000 Sw 97th Avenue # 106 in Miami, Florida 33173.
For its online presence, you may visit In Mirisan Rehabilitation’s website at and engage with its social media outlets through on Twitter and on Facebook.